The growth of weight-loss drugs is leading to an increase of global demand for fish.
Reports indicate the rise of GLP-1 treatments is encouraging people to seek out more nutrient-dense food - and that's good news for New Zealand's open ocean fish farmers.
The Country's Jamie Mackay explained further.
LISTEN ABOVE

Paul Bloxham: HSBC chief economist on whether the RBA is set to lift the OCR again
03:20

Adrian Daniel: streetwear influencer on the impact of Nike falling out of the S&P 100
03:14

Michael Reddell: former Reserve Bank economist on the review into the RBNZ's Covid-19 response
03:56